21 - 21 (out of 21)

SMASH Splice Modulation Approach to suppress HFpEF
Targeted inhibition of the titin splice factor RBM20 using antisense oligonucleotides (ASOs) offers a novel approach for treating heart failure with preserved ejection fraction (HFpEF) and is being advanced through preclinical studies.
Principal Investigators | Michael Gotthardt, Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft; Alessio Alogna, Deutsches Herzzentrum der Charité |
---|---|
Project status |